Avante Corp. achieved 10% year-over-year revenue growth in fiscal second quarter ended September 30, 2025, driven by 47% ...

Following the recent unveiling of its new long-term strategy to 2030, eDreams ODIGEO (hereinafter 'eDO' or 'the Company') today confirmed and expanded on its short-term guidance announced last week ...

Afqlir® is indicated to improve and maintain visual acuity in patients with nAMD, macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME) and myopic choroidal ...

Summarises how WIP is recognised and measured under Ind AS 115/IFRS 15, emphasising cost tracking, progress measurement, and disclosure rules for service ...

Detailed price information for Poet Technologies Inc (POET-Q) from The Globe and Mail including charting and trades.

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance ...

Nigeria was the first country to adopt the IFRS S1 & S2 Sustainability Standards in Africa and among the first globally, through the Financial Reporting Council (FRC) of Nigeria. One major issue with ...

Securities and Exchange Commission chairman Paul Atkins issued a warning that the SEC might eliminate a rule that allows multinational companies to present their financial statements in accordance ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

In June 2023, the International Financial Reporting Standards (IFRS) Foundation introduced its inaugural global Sustainability Disclosure Standards, IFRS S1 and IFRS S2. This marks a new era for how ...

It is in metrics and targets that actual performance can be assessed by users of GPFR. Baseline metrics are established in the first year of adoption and subsequent years’ comparative metrics and ...

We examine whether the accounting treatment of R&D is a credible signal for the firm’s future performance, both operating and financial. We examine Greek-listed firms that report under IFRS. IAS 38 ...